Joel Baumgartner

Title(s)Professor Of Clinical, Surgery
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Joel M. Baumgartner, MD is a surgical oncologist with expertise in cancers of the GI tract and melanoma. He is board certified in general surgery and completed a surgical oncology fellowship at the University of Pittsburgh with a focus on clinical research, which included additional training in the development and conduct of clinical trials.

    Dr. Baumgartner has specific expertise and interest in treating tumors that have metastasized to the abdomen, using a promising treatment known as the “chemo bath" or hyperthermic (heated) intraperitoneal chemotherapy (HIPEC). This treatment involves surgical resection of all tumors followed by circulation of heated chemotherapy throughout the abdomen. This technique avoids many of the toxicities associated with systemic chemotherapy, while exposing the abdomen to higher concentrations of chemotherapy. Dr. Baumgartner spent two years working and training at one of highest volume HIPEC centers in the world at the University of Pittsburgh and therefore has significant experience with this procedure.

    Dr. Baumgartner also treats melanoma and performs wide local excision of these tumors, sentinel lymph node biopsies and lymph node dissections.

    Dr. Baumgartner is a member of numerous societies including the Society of Surgical Oncology, the American Society of Clinical Oncology and is an associate member of the American Association for Cancer Research and the American College of Surgeons. His research interests are in clinical trials, HIPEC, melanoma and immunotherapy.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cyclin-Dependent Kinase 4/6 Inhibition as a Novel Therapy for Peritoneal Mucinous Carcinomatosis With GNAS Mutations. J Clin Oncol. 2024 Oct 16; JCO2400511. Weitz J, Nishizaki D, Liau J, Patel J, Ng I, Sun S, Ramms D, Zou J, Wishart B, Rull J, Baumgartner J, Kelly K, White R, Veerapong J, Hosseini M, Patel H, Botta G, Gutkind JS, Tiriac H, Kato S, Lowy AM. PMID: 39413348.
      View in: PubMed   Mentions:    Fields:    
    2. Development of a predictive model for risk stratification of acute kidney injury in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Sci Rep. 2024 03 19; 14(1):6630. Krause M, Mehdipour S, Veerapong J, Baumgartner JM, Lowy AM, Gabriel RA. PMID: 38503776; PMCID: PMC10951241.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative. Ann Surg Oncol. 2024 May; 31(5):3314-3324. Fackche NT, Schmocker RK, Nudotor R, Kubi B, Cloyd JM, Grotz TE, Fournier KF, Dineen SP, Veerapong J, Baumgartner JM, Clarke CN, Patel SH, Wilson GC, Lambert LA, Pokrzywa C, Abbott DE, Lee B, Staley CA, Zaidi MY, Johnston FM, Greer JB. PMID: 38310181.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2024 01; 293:403-412. Florissi I, Radomski SN, Shou B, Cloyd JM, Kim A, Grotz T, Fournier K, Baumgartner JM, Lambert L, Abbott DE, Schwartz P, Staley CA, Clarke C, Dineen S, Patel SH, Wilson GC, Raoof M, Johnston FM, Greer JB. PMID: 37806228.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy. Ann Surg Oncol. 2023 Nov; 30(12):7840-7847. Winicki NM, Radomski SN, Florissi IS, Cloyd JM, Gutta G, Grotz TE, Scally CP, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Kothari AN, Maduekwe UN, Patel SH, Wilson GC, Schwartz P, Varley PR, Raoof M, Lee B, Malik I, Johnston FM, Greer JB. PMID: 37620532; PMCID: PMC10592201.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Role of Circulating Tumor DNA Among Patients with Colorectal Peritoneal Metastases. J Gastrointest Cancer. 2024 Mar; 55(1):41-46. Baumgartner JM, Botta GP. PMID: 37436640; PMCID: PMC11096195.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a prospective clinical trial and comparative analysis. Surg Endosc. 2023 07; 37(7):5644-5651. Cho CY, Veerapong J, Baumgartner JM, Murphy JD, Lowy AM, Kelly KJ. PMID: 36477643; PMCID: PMC10322763.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    8. Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC. J Surg Oncol. 2023 Mar; 127(4):706-715. Kubi B, Nudotor R, Fackche N, Rowe J, Cloyd JM, Ahmed A, Grotz TE, Fournier K, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB. PMID: 36468401.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. ASO Author Reflections: Routine Omentectomy During Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2023 02; 30(2):774-775. Khan S, Baumgartner JM. PMID: 36367628; PMCID: PMC9807545.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape. Clin Cancer Res. 2022 11 01; 28(21):4793-4806. Weitz J, Hurtado de Mendoza T, Tiriac H, Lee J, Sun S, Garg B, Patel J, Li K, Baumgartner J, Kelly KJ, Veerapong J, Hosseini M, Chen Y, Lowy AM. PMID: 36067351.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    11. Is Routine Omentectomy a Necessary Component of Cytoreductive Surgery and HIPEC? Ann Surg Oncol. 2023 Feb; 30(2):768-773. Khan S, Doan NH, Hosseini M, Kelly K, Veerapong J, Lowy AM, Baumgartner J. PMID: 36305990; PMCID: PMC9807473.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Alvimopan for Enhanced Gastrointestinal Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Randomized Controlled Trial. J Am Coll Surg. 2022 11 01; 235(5):693-701. Baumgartner JM, Chen R, Messer K, Veerapong J, Kelly KJ, Ramamoorthy S, Lowy AM. PMID: 36102565.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series. Ann Surg Oncol. 2022 Nov; 29(12):7542-7548. Courelli AS, Sharma AK, Madlensky L, Choi YY, Li S, Sarno S, Kelly K, Mehtsun W, Horgan S, Harismendy O, Baumgartner JM, Sicklick JK. PMID: 35849291; PMCID: PMC10226389.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Palbociclib as a Novel Therapy for Low-Grade Mucinous Carcinomatosis Peritonei of Appendiceal Origin. JCO Precis Oncol. 2021 11; 5:1069-1072. Childers BG, Sood D, Patel R, Mose ES, Hosseini M, Kato S, Baumgartner JM, Lowy AM. PMID: 34994628.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC Collaborative. J Gastrointest Surg. 2022 02; 26(2):414-424. Nizam W, Fackche N, Pessoa B, Kubi B, Cloyd JM, Grotz T, Fournier K, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Wilson GC, Lambert L, Abbott DE, Vande Walle KA, Lee B, Raoof M, Maithel SK, Russell MC, Zaidi MY, Johnston FM, Greer JB. PMID: 34506026.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. J Gastrointest Surg. 2021 11; 25(11):2908-2919. Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB. PMID: 33634422.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis. Ann Surg Oncol. 2021 Aug; 28(8):4499-4507. Kubi B, Nudotor R, Fackche N, Nizam W, Cloyd JM, Grotz TE, Fournier KF, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Patel SH, Lambert LA, Abbott DE, Vande Walle KA, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Greer JB. PMID: 33507449.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    18. A Multi-institutional Study of Peritoneal Recurrence Following Resection of Low-grade Appendiceal Mucinous Neoplasms. Ann Surg Oncol. 2021 Aug; 28(8):4685-4694. Baumgartner JM, Srivastava A, Melnitchouk N, Drage MG, Huber AR, Gonzalez RS, Bell P, Wu E, Resnick M, Turaga K, Poli E, Esquivel J, Deneve J, Kelly KJ, Veerapong J, Lowy AM. PMID: 33415564.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Preoperative bevacizumab does not increase complications following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. PLoS One. 2020; 15(12):e0243252. King BH, Baumgartner JM, Kelly KJ, Marmor RA, Lowy AM, Veerapong J. PMID: 33270763; PMCID: PMC7714141.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. A multi-institutional analysis of Textbook Outcomes among patients undergoing cytoreductive surgery for peritoneal surface malignancies. Surg Oncol. 2021 Jun; 37:101492. Wiseman JT, Abdel-Misih S, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Eng O, Fackche N, Greer J, Pawlik TM, Cloyd JM. PMID: 33465587.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative. Ann Surg Oncol. 2020 Dec; 27(13):4996-5004. Roife D, Powers BD, Zaidi MY, Staley CA, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lee B, Blakely A, Greer J, Johnston FM, Laskowitz D, Dessureault S, Dineen SP. PMID: 33073341.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    22. A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC. J Surg Oncol. 2021 Jan; 123(1):187-195. Lee RM, Gamboa AC, Turgeon MK, Zaidi MY, Kimbrough C, Leiting J, Grotz T, Lee AJ, Fournier K, Powers B, Dineen S, Baumgartner JM, Veerapong J, Mogal H, Clarke C, Wilson G, Patel S, Hendrix R, Lambert L, Pokrzywa C, Abbott DE, LaRocca CJ, Raoof M, Greer J, Johnston FM, Staley CA, Cloyd JM, Maithel SK, Russell MC. PMID: 33002202; PMCID: PMC7957345.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases. Ann Surg Oncol. 2020 Sep; 27(9):3259-3267. Baumgartner JM, Riviere P, Lanman RB, Kelly KJ, Veerapong J, Lowy AM, Kurzrock R. PMID: 32767050; PMCID: PMC7470602.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol. 2020 Dec; 27(13):4980-4995. Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA. PMID: 32696303; PMCID: PMC7988818.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    25. Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative. World J Gastrointest Oncol. 2020 Jul 15; 12(7):756-767. Leiting JL, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dessureault S, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Zaidi MY, Patel SH, Ahmad SA, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, LaRocca CJ, Johnston FM, Greer J, Grotz TE. PMID: 32864043; PMCID: PMC7428797.
      View in: PubMed   Mentions: 14  
    26. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. J Surg Oncol. 2020 Oct; 122(5):980-985. Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston FM, Dineen S, Powers B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Walle KV, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M. PMID: 32627199.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    27. Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2020 11; 255:475-485. Kubi B, Gunn J, Fackche N, Cloyd JM, Abdel-Misih S, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Patel SH, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Wang NY, Greer JB. PMID: 32622162.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study. Ann Surg Oncol. 2020 Dec; 27(13):4883-4891. Powers BD, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Maithel SK, Patel S, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Johnston FM, Greer J, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Imanirad I, Dessureault S, Dineen SP. PMID: 32318945.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    29. ASO Author Reflections: Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases. Ann Surg Oncol. 2020 Sep; 27(9):3268-3269. Baumgartner JM, Riviere P, Kurzrock R. PMID: 32303875.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Impact of Neoadjuvant Chemotherapy on the Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Multi-Institutional Retrospective Review. J Clin Med. 2020 Mar 10; 9(3). Beal EW, Suarez-Kelly LP, Kimbrough CW, Johnston FM, Greer J, Abbott DE, Pokrzywa C, Raoof M, Lee B, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Dhar V, Lambert L, Hendrix RJ, Hays J, Abdel-Misih S, Cloyd JM. PMID: 32164300; PMCID: PMC7141272.
      View in: PubMed   Mentions: 8  
    31. The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. Int J Hyperthermia. 2020; 37(1):1182-1188. Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Eng O, Johnston FM, Greer J, Grotz TE. PMID: 33040617.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. J Gastrointest Surg. 2020 01; 24(1):165-176. Lee TC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Zaidi MY, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Greer J, Patel SH. PMID: 31745888.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    33. Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? Ann Surg Oncol. 2020 Mar; 27(3):783-792. Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM. PMID: 31659645.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    34. ASO Author Reflections: Venous Thromboembolism after CRS/HIPEC. Ann Surg Oncol. 2019 12; 26(Suppl 3):758-759. Baumgartner JM, Khan S. PMID: 31576472.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Trends in the indications for and short-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Am J Surg. 2020 03; 219(3):478-483. Beal EW, Ahmed A, Grotz T, Leiting J, Fournier KF, Lee AJ, Dineen S, Dessureault S, Baumgartner JM, Veerapong J, Clarke C, Strong E, Maithel SK, Zaidi MY, Patel S, Dhar V, Hendrix R, Lambert L, Johnston F, Fackche N, Raoof M, LaRocca C, Ronnekleiv-Kelly S, Pokrzywa C, Pawlik TM, Abdel-Misih S, Cloyd JM. PMID: 31558307.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    36. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. J Gastrointest Surg. 2020 01; 24(1):155-164. Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH. PMID: 31428960.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    37. Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3611-3617. Baumgartner JM, Marmor R, Hsu A, Veerapong J, Kelly KJ, Lowy AM. PMID: 31190209.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2019 Jul; 26(7):2276-2284. Khan S, Kelly KJ, Veerapong J, Lowy AM, Baumgartner JM. PMID: 31065960.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    39. Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. Ann Surg Oncol. 2019 Jul; 26(7):2234-2240. Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ. PMID: 31016486.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    40. Does Primary Tumor Side Matter in Patients with Metastatic Colon Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? Ann Surg Oncol. 2019 May; 26(5):1421-1427. Kelly KJ, Alsayadnasser M, Vaida F, Veerapong J, Baumgartner JM, Patel S, Ahmad S, Barone R, Lowy AM. PMID: 30815802.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    41. ASO Author Reflections: Circulating Tumor DNA in Peritoneal Carcinomatosis. Ann Surg Oncol. 2018 12; 25(Suppl 3):772-773. Baumgartner JM, Kurzrock R. PMID: 30421042.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. ASO Author Reflections: Recurrence Predictors in Mucinous Appendiceal Tumors. Ann Surg Oncol. 2018 12; 25(Suppl 3):763-764. Baumgartner JM. PMID: 30411269.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma. Clin Cancer Res. 2018 12 15; 24(24):6248-6256. Kato S, Okamura R, Baumgartner JM, Patel H, Leichman L, Kelly K, Sicklick JK, Fanta PT, Lippman SM, Kurzrock R. PMID: 30348637; PMCID: PMC6384095.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    44. Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal Mesothelioma. J Gastrointest Surg. 2019 04; 23(4):879-881. de la Torre J, Banerjee S, Baumgartner J, Lin GY, Burgoyne AM, Kirane A, Sicklick J. PMID: 30132292; PMCID: PMC6384158.
      View in: PubMed   Mentions: 4     Fields:    
    45. Genomic Landscape of Appendiceal Neoplasms. JCO Precis Oncol. 2018; 2. Ang CS, Shen JP, Hardy-Abeloos CJ, Huang JK, Ross JS, Miller VA, Jacobs MT, Chen IL, Xu D, Ali SM, Baumgartner J, Lowy A, Fanta P, Ideker T, Millis SZ, Harismendy O. PMID: 32913983; PMCID: PMC7446344.
      View in: PubMed   Mentions: 23     Fields:    
    46. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival. Ann Surg Oncol. 2018 Aug; 25(8):2400-2408. Baumgartner JM, Raymond VM, Lanman RB, Tran L, Kelly KJ, Lowy AM, Kurzrock R. PMID: 29948422; PMCID: PMC6044413.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    47. The Use of Solicited Publishing by Academic Surgeons. Surgery. 2018 08; 164(2):212-218. Nguyen V, Marmor RA, Ramamoorthy SL, Costantini TW, Baumgartner JM, Berumen J, Jacobsen GR, Sicklick JK. PMID: 29724409; PMCID: PMC6074048.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    48. Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients. World J Surg Oncol. 2018 Apr 26; 16(1):87. Weiss A, Ward EP, Baumgartner JM, Lowy AM, Kelly KJ. PMID: 29699564; PMCID: PMC5922306.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    49. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience. Ann Surg Oncol. 2018 May; 25(5):1184-1192. Liu Y, Yonemura Y, Levine EA, Glehen O, Goere D, Elias D, Morris DL, Sugarbaker PH, Tuech JJ, Cashin P, Spiliotis JD, de Hingh I, Ceelen W, Baumgartner JM, Piso P, Katayama K, Deraco M, Kusamura S, Pocard M, Quenet F, Fushita S, BIG-RENAPE Group. PMID: 29484565; PMCID: PMC5891561.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    50. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC. Ann Surg Oncol. 2018 Mar; 25(3):702-708. Reghunathan M, Kelly KJ, Valasek MA, Lowy AM, Baumgartner JM. PMID: 29282599.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    51. The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA. Mol Cancer Ther. 2018 01; 17(1):297-305. Riviere P, Fanta PT, Ikeda S, Baumgartner J, Heestand GM, Kurzrock R. PMID: 29133621; PMCID: PMC5752585.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    52. Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2018 Jan; 25(1):91-97. Kelly KJ, Cajas L, Baumgartner JM, Lowy AM. PMID: 29090402.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    53. Prophylactic enoxaparin doses may be inadequate in patients undergoing abdominal cancer surgery. J Surg Res. 2018 01; 221:183-189. Baumgartner JM, McKenzie S, Block S, Costantini TW, Lowy AM. PMID: 29229126.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care. PLoS One. 2017; 12(6):e0179216. Valasek MA, Thung I, Gollapalle E, Hodkoff AA, Kelly KJ, Baumgartner JM, Vavinskaya V, Lin GY, Tipps AP, Hosseini MV, Lowy AM. PMID: 28591173; PMCID: PMC5462425.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. J Natl Compr Canc Netw. 2016 11; 14(11):1357-1370. VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A. PMID: 27799507.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    56. Low-Grade Appendiceal Mucinous Neoplasm Involving the Endometrium and Presenting with Mucinous Vaginal Discharge. Case Rep Obstet Gynecol. 2016; 2016:6841989. Vavinskaya V, Baumgartner JM, Ko A, Saenz CC, Valasek MA. PMID: 27843660; PMCID: PMC5097800.
      View in: PubMed   Mentions: 3  
    57. Are self-identified "disadvantaged" students less likely to enter surgical residencies? A single-institution study. J Surg Res. 2016 05 15; 202(2):253-8. Unkart JT, Reid CM, Baumgartner JM, Wallace AM, Kelly CJ. PMID: 27229098.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2016 May; 23(5):1609-17. Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. PMID: 26678406; PMCID: PMC5841914.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    59. Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery. Ann Surg Oncol. 2016 May; 23(5):1461-7. Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM. PMID: 26542584.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    60. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study. Cancer. 2015 Sep 01; 121(17):2960-7. Murphy JD, Ma GL, Baumgartner JM, Madlensky L, Burgoyne AM, Tang CM, Martinez ME, Sicklick JK. PMID: 25930983; PMCID: PMC4545693.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    61. Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei. Ann Surg Oncol. 2015 May; 22(5):1722-5. Kelly KJ, Baumgartner JM, Lowy AM. PMID: 25395145.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    62. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015 May; 22(5):1716-21. Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. PMID: 25145504.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    63. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014 Dec; 110(7):779-85. Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R. PMID: 25088304.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    64. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Ann Surg Oncol. 2014 Dec; 21(13):4195-201. Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R. PMID: 24854493.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    65. Improved perioperative outcomes with minimally invasive distal pancreatectomy: results from a population-based analysis. JAMA Surg. 2014 Mar; 149(3):237-43. Tran Cao HS, Lopez N, Chang DC, Lowy AM, Bouvet M, Baumgartner JM, Talamini MA, Sicklick JK. PMID: 24402232; PMCID: PMC4383084.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    66. Aggressive locoregional management of recurrent peritoneal sarcomatosis. J Surg Oncol. 2013 Mar; 107(4):329-34. Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA. PMID: 23386388.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    67. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg. 2012 Jun; 16(6):1152-9. Baumgartner JM, Krasinskas A, Daouadi M, Zureikat A, Marsh W, Lee K, Bartlett D, Moser AJ, Zeh HJ. PMID: 22399269.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    68. DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors. J Surg Res. 2012 Jul; 176(1):301-8. Baumgartner JM, Jordan KR, Hu LJ, Wilson CC, Banerjee A, McCarter MD. PMID: 21962733; PMCID: PMC4674430.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    69. Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J Interferon Cytokine Res. 2009 Jun; 29(6):333-8. Baumgartner JM, Nydam TL, Clarke JH, Banerjee A, Silliman CC, McCarter MD. PMID: 19441884; PMCID: PMC2956619.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    70. Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery. Surgery. 2009 Apr; 145(4):345-50. Baumgartner JM, McCarter MD. PMID: 19303982.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    71. Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg. 2009 Jan; 208(1):110-9. Baumgartner JM, Silliman CC, Moore EE, Banerjee A, McCarter MD. PMID: 19228512; PMCID: PMC5787354.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    72. Increased survival from stage IV melanoma associated with fewer regulatory T Cells. J Surg Res. 2009 Jun 01; 154(1):13-20. Baumgartner JM, Gonzalez R, Lewis KD, Robinson WA, Richter DA, Palmer BE, Wilson CC, McCarter MD. PMID: 19062042.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells